DASFREE: Treatment-Free Remission (TFR) After Discontinuation of Dasatinib in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) and Deep Molecular Response (DMR)

著录项

• 来源
  《Clinical lymphoma, myeloma & leukemia》 |2019年第1期|共1页
• 作者

  Shah Neil P.; Garcia-Gutierrez Valentin; Jimenez-Velasco Antonio; Larson Sarah; Saussele Susanne; Rea Delphine; Mahon Francois-Xavier; Levy Moshe Yair; Teresa Gomez-Casares Maria; Luciano Luigia; Nicolini Franck-Emmanuel; Mauro Michael J.; Sy Oumar; Martin-Regueira Patricia; Lipton Jeffrey H.;

  展开▼
• 作者单位

  UCSF Sch Med Dept Med Hematol Oncol San Francisco CA USA;

  Hosp Univ Ramon Y Cajal IRYCIS Serv Hematol &

  Hemoterapia Madrid Spain;

  Hosp Univ Carlos Haya Malaga Spain;

  Univ Calif Los Angeles David Geffen Sch Med Los Angeles CA 90095 USA;

  Heidelberg Univ Univ Hosp Mannheim Dept Hematol &

  Oncol Heidelberg Germany;

  Hop St Louis Hematol Paris France;

  Univ Bordeaux Segalen Hematol Bordeaux France;

  Baylor Charles A Sammons Canc Ctr Dallas TX USA;

  Hosp Univ Gran Canaria Dr Negrin Las Palmas Gran Canaria Spain;

  Univ Napoli Federico II Naples Italy;

  Ctr Leon Berard Hematol Clin 1G Lyon France;

  Mem Sloan Kettering Canc Ctr Myeloproliferat Neoplasms Program 1275 York Ave New York NY 10021;

  Bristol Myers Squibb Princeton NJ USA;

  Bristol Myers Squibb Princeton NJ USA;

  Univ Toronto Princess Margaret Canc Ctr Canc Clin Res Unit Toronto ON Canada;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 肿瘤学;
• 关键词

  treatment-free remission; dasatinib; imatinib; CML-CP; CML; chronic myelogenous leukemia;

  机译：无喉杆菌;达斯替尼;伊马替尼;CML-CP;CML;慢性髓性白血病;